Mapping histamine H4 receptor–ligand binding modes

The increasing number of G protein-coupled receptor (GPCR) crystal structures offers new opportunities for histamine receptor homology modeling. However, computational prediction of ligand binding modes in GPCRs such as the histamine H4 receptor (H4R), a receptor that plays an important role in inflammation, remains a challenging task. In the current work we have combined complementary in silico receptor modeling approaches with in vitro ligand structure–activity relationship (SAR) and protein site-directed mutagenesis studies to elucidate the binding modes of different ligand classes in H4R. By systematically considering different H4R modelling templates, ligand binding poses, and ligand protonation states in combination with docking and MD simulations we are able to explain ligand-specific mutation effects and subtle differences in ligand SAR. Our studies confirm that a combined theoretical and experimental approach represents a powerful strategy to map ligand–protein interactions.

[1]  M. Trevethick,et al.  IDENTIFICATION OF A HISTAMINE H4 RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS , 2002, Journal of receptor and signal transduction research.

[2]  R. Smits,et al.  Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. , 2006, Journal of medicinal chemistry.

[3]  R. Thurmond,et al.  Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines , 2010, Respiratory research.

[4]  Leonardo Pardo,et al.  An Activation Switch in the Rhodopsin Family of G Protein-coupled Receptors , 2005, Journal of Biological Chemistry.

[5]  A. Strasser,et al.  Synthesis and Structure−Activity Relationships of Cyanoguanidine-Type and Structurally Related Histamine H4 Receptor Agonists§ , 2009 .

[6]  Triamino pyrimidines and pyridines as histamine H(4) receptor modulators. , 2011, Bioorganic & medicinal chemistry letters.

[7]  C. Mowbray,et al.  Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist. , 2011, Bioorganic & medicinal chemistry letters.

[8]  Yan Li,et al.  Studies of H4R antagonists using 3D-QSAR, molecular docking and molecular dynamics , 2012, Journal of Molecular Modeling.

[9]  Roland Seifert,et al.  Structural Requirements for Inverse Agonism and Neutral Antagonism of Indole-, Benzimidazole-, and Thienopyrrole-Derived Histamine H4 Receptor Ligands , 2010, Journal of Pharmacology and Experimental Therapeutics.

[10]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[11]  R. Stevens,et al.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor. , 2011, Journal of medicinal chemistry.

[12]  I. D. de Esch,et al.  Molecular determinants of selective agonist and antagonist binding to the histamine H₄ receptor. , 2011, Current topics in medicinal chemistry.

[13]  Lei Shi,et al.  The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. , 2002, Annual review of pharmacology and toxicology.

[14]  Ola Engkvist,et al.  Molecular modeling of the second extracellular loop of G‐protein coupled receptors and its implication on structure‐based virtual screening , 2008, Proteins.

[15]  H. Stark,et al.  Histamine H4 receptor antagonism reduces hapten‐induced scratching behaviour but not inflammation , 2009, Experimental dermatology.

[16]  Wen Jiang,et al.  Molecular Determinants of Ligand Binding to H4R Species Variants , 2010, Molecular Pharmacology.

[17]  H. Timmerman,et al.  Studies on histaminergic compounds. II: Synthesis and histamine H2-activity of dimaprit and some of its analogues , 1984 .

[18]  I. D. de Esch,et al.  Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. , 2007, European journal of pharmacology.

[19]  R. Smits,et al.  The emerging role of the histamine H4 receptor in anti-inflammatory therapy. , 2006, Current topics in medicinal chemistry.

[20]  Saskia Nijmeijer,et al.  Triazole ligands reveal distinct molecular features that induce histamine H4 receptor affinity and subtly govern H4/H3 subtype selectivity. , 2011, Journal of medicinal chemistry.

[21]  Albert C. Pan,et al.  Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.

[22]  Thomas Stützle,et al.  PLANTS: Application of Ant Colony Optimization to Structure-Based Drug Design , 2006, ANTS Workshop.

[23]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[24]  Lars Karlsson,et al.  A Potent and Selective Histamine H4 Receptor Antagonist with Anti-Inflammatory Properties , 2004, Journal of Pharmacology and Experimental Therapeutics.

[25]  J. A. Jablonowski,et al.  The first potent and selective non-imidazole human histamine H4 receptor antagonists. , 2003, Journal of medicinal chemistry.

[26]  Ruben Abagyan,et al.  Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.

[27]  Chris Oostenbrink,et al.  Improved ligand-protein binding affinity predictions using multiple binding modes. , 2010, Biophysical journal.

[28]  Vadim Cherezov,et al.  Diversity and modularity of G protein-coupled receptor structures. , 2012, Trends in pharmacological sciences.

[29]  G. Schneider,et al.  Homology Model Adjustment and Ligand Screening with a Pseudoreceptor of the Human Histamine H4 Receptor , 2009, ChemMedChem.

[30]  Didier Rognan,et al.  A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors , 2005, Proteins.

[31]  I. D. de Esch,et al.  Phenylalanine 169 in the Second Extracellular Loop of the Human Histamine H4 Receptor Is Responsible for the Difference in Agonist Binding between Human and Mouse H4 Receptors , 2008, Journal of Pharmacology and Experimental Therapeutics.

[32]  R. Thurmond,et al.  Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation , 2004, British journal of pharmacology.

[33]  R. Smits,et al.  Major advances in the development of histamine H4 receptor ligands. , 2009, Drug discovery today.

[34]  Didier Rognan,et al.  Customizing G Protein-coupled receptor models for structure-based virtual screening. , 2009, Current pharmaceutical design.

[35]  Jacob D. Durrant,et al.  POVME: an algorithm for measuring binding-pocket volumes. , 2011, Journal of molecular graphics & modelling.

[36]  Gisbert Schneider,et al.  In Silico Characterization of Ligand Binding Modes in the Human Histamine H4 Receptor and their Impact on Receptor Activation , 2010, Chembiochem : a European journal of chemical biology.

[37]  J. Montgomery,et al.  Carbon-13 nuclear magnetic resonance study of protonation of methotrexate and aminopterin bound to dihydrofolate reductase. , 1981, Biochemistry.

[38]  R. Smits,et al.  Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands. , 2012, European journal of medicinal chemistry.

[39]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[40]  Jill M. Wetter,et al.  H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats , 2010, Pharmacology Biochemistry and Behavior.

[41]  K. Tam,et al.  Multiwavelength spectrophotometric determination of acid dissociation constants of ionizable drugs. , 1998, Journal of pharmaceutical and biomedical analysis.

[42]  R. Leurs,et al.  A Gq/11-coupled Mutant Histamine H1 Receptor F435A Activated Solely by Synthetic Ligands (RASSL)* , 2005, Journal of Biological Chemistry.

[43]  Jill M. Wetter,et al.  Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands. , 2008, Journal of medicinal chemistry.

[44]  Chris de Graaf,et al.  Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation. , 2005, Journal of medicinal chemistry.

[45]  Richard A Friesner,et al.  Successful prediction of the intra- and extracellular loops of four G-protein-coupled receptors , 2011, Proceedings of the National Academy of Sciences.

[46]  Gisbert Schneider,et al.  2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization. , 2009, Bioorganic & medicinal chemistry.

[47]  Gerhard Klebe,et al.  Development, validation, and application of adapted PEOE charges to estimate pKa values of functional groups in protein–ligand complexes , 2006, Proteins.

[48]  R. Thurmond,et al.  The Histamine H4 Receptor Mediates Allergic Airway Inflammation by Regulating the Activation of CD4+ T Cells , 2006, The Journal of Immunology.

[49]  E. Bosch,et al.  Potentiometric and spectrophotometric pKa determination of water-insoluble compounds: validation study in a new cosolvent system. , 2007, Analytica chimica acta.

[50]  P. Desai,et al.  Histamine H4 Receptor Mediates Chemotaxis and Calcium Mobilization of Mast Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[51]  Iwan J. P. de Esch,et al.  Delineation of Agonist Binding to the Human Histamine H4 Receptor Using Mutational Analysis, Homology Modeling, and ab Initio Calculations , 2008, J. Chem. Inf. Model..

[52]  Gilles Marcou,et al.  Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints , 2007, J. Chem. Inf. Model..

[53]  Yi-Jun Guo,et al.  Molecular basis for the interaction of histamine with the histamine H2 receptor. , 1992, The Journal of biological chemistry.

[54]  F. Gantner,et al.  Histamine H4 and H2 Receptors Control Histamine-Induced Interleukin-16 Release from Human CD8+ T Cells , 2002, Journal of Pharmacology and Experimental Therapeutics.

[55]  F. Monsma,et al.  Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor. , 2002, Molecular pharmacology.

[56]  Nicholas J. Carruthers,et al.  Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. , 2001, Molecular pharmacology.

[57]  Philip C Biggin,et al.  Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis. , 2012, Biochemistry.

[58]  Thomas Stützle,et al.  Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS , 2009, J. Chem. Inf. Model..

[59]  Béla Noszál,et al.  Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor. , 2008, European journal of medicinal chemistry.

[60]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[61]  P. Desai,et al.  Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. , 2007, The Journal of allergy and clinical immunology.

[62]  Rob Leurs,et al.  Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist , 2005, Journal of Pharmacology and Experimental Therapeutics.

[63]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[64]  Béla Noszál,et al.  Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening. , 2008, Journal of medicinal chemistry.

[65]  Jill M. Wetter,et al.  Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. , 2008, Journal of medicinal chemistry.

[66]  J. A. Jablonowski,et al.  Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists. , 2005, Journal of medicinal chemistry.

[67]  H Hayashi,et al.  Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194. , 1994, Biochemical and biophysical research communications.

[68]  Saskia Nijmeijer,et al.  Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies. , 2011, Journal of medicinal chemistry.